Ryan M Schmaltz, Age 42105 Oakbrook Ln, The Geysers, CA 95425

Ryan Schmaltz Phones & Addresses

105 Oakbrook Ln, Cloverdale, CA 95425 (707) 894-6078

Westerville, OH

La Jolla, CA

2217 Sutter Pkwy, Dublin, OH 43016 (614) 761-2827

Charlottesville, VA

Chandler, AZ

5878 Tournament Dr, Westerville, OH 43082 (614) 226-7580

Show more

Work

Position: Sales Occupations

Education

Degree: High school graduate or higher

Mentions for Ryan M Schmaltz

Ryan Schmaltz resumes & CV records

Resumes

Ryan Schmaltz Photo 19

Human Resources Representative

Location:
Chicago, IL
Work:
Iu Health La Porte Hospital
Human Resources Representative
Education:
Purdue University Northwest
Ryan Schmaltz Photo 20

Director Of Winemaking

Location:
105 Oakbrook Ln, Cloverdale, CA 95425
Industry:
Wine And Spirits
Work:
Trattore Farms and Winery May 2017 - Mar 2019
Winemaker
Trattore Farms and Winery May 2016 - May 2017
Assistant Winemaker
The Scripps Research Institute Oct 2010 - May 2012
Postdoctoral Researcher
Bella Vineyards Oct 2010 - May 2012
Director of Winemaking
Education:
University of Virginia 2005 - 2010
Doctorates, Doctor of Philosophy, Philosophy, Organic Chemistry
Miami University 2002 - 2005
Bachelors, Organic Chemistry
Skills:
Wine, Chemistry, Sensory Evaluation

Publications & IP owners

Us Patents

Carbohydrate-Mediated Tumor Targeting

US Patent:
2012014, Jun 14, 2012
Filed:
May 5, 2010
Appl. No.:
13/382581
Inventors:
Sidney Hecht - Phoenix AZ, US
Ryan Schmaltz - La Jolla CA, US
Krystal Tsosie - Phoenix AZ, US
Assignee:
Arizona Board of Regents, a body corporate of the State of Ariz. acting for and on behalf of Ariz. - Scottdale AZ
International Classification:
A61K 49/22
A61K 38/14
A61P 35/00
C07H 15/26
A61K 31/7056
C07K 9/00
A61K 49/00
US Classification:
424 952, 530322, 514 209, 424 96, 514 193, 424 941, 536 179, 536 174, 514 25
Abstract:
Tumors can be selectively targeted via compounds provided herein according to the formula, or a pharmaceutically acceptable salt thereof, wherein Rand Rare as defined herein. Tumors can be imaged or targeted for therapeutic treatment using compounds described herein where at least one Ror at least one Rgroup comprises a imaging agent, a therapeutic agent, or a member of a specific binding pair which can be associated with a secondary imaging agent, such as a microbubble for ultrasonic imaging.

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.